Progression of kidney disease: Blocking leukocyte recruitment with chemokine receptor CCR1 antagonists

Kidney International

Volumn 69, Issue 1, 2006, Pages 29-32

  Anders, H J ^a   Ninichuk, V ^a   Schlondorff, D ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Chemokines; Chronic kidney disease; Inflammation; Leukocytes; Progression

Indexed keywords

1 [5 CHLORO 2 [2 [4 (4 FLUOROBENZYL) 2 METHYL 1 PIPERAZINYL] 2 OXOETHOXY]PHENYL]UREA; CHEMOKINE; CHEMOKINE RECEPTOR ANTAGONIST; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR1 ANTAGONIST; CYTOKINE; DOXORUBICIN; UNCLASSIFIED DRUG;

ALPORT SYNDROME; CELL INFILTRATION; CHRONIC KIDNEY DISEASE; CYTOKINE PRODUCTION; DIABETIC NEPHROPATHY; DISEASE COURSE; DRUG TARGETING; GLOMERULONEPHRITIS; LEUKOCYTE; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; NEPHROTIC SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL GRAFT DYSFUNCTION; SHORT SURVEY; URETER OBSTRUCTION; VASCULAR ENDOTHELIUM;

ANIMALS; CELL MOVEMENT; COLLAGEN TYPE IV; DISEASE PROGRESSION; DOXORUBICIN; HUMANS; KIDNEY DISEASES; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; LEUKOCYTES; RECEPTORS, CHEMOKINE; TRANSPLANTATION, HOMOLOGOUS;

EID: 30944441131     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000053     Document Type: Short Survey

References (20)

1. Eddy AA. Molecular basis of renal fibrosis. Pediatr Nephrol 2000; 15: 290-301.
2. Murphy PM. International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacol Rev 2002; 54: 227-229.
3. Kaufmann A, Salentin R, Gemsa D et al. Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1 alpha during differentiation of human monocytes to macrophages. J Leukoc Biol 2001; 69: 248-252.
4. Kluth DC, Erwig LP, Rees AJ. Multiple facets of macrophages in renal injury. Kidney Int 2004; 66: 542-557.
5. Weber C, Weber KS, Klier C et al. Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of monocytes and Th1-like/CD45RO(+) T cells. Blood 2001; 97: 1144-1146.
6. Ninichuk V, Gross O, Reichel C et al. Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease. J Am Soc Nephrol 2005; 16: 977-985.
7. Gao JL, Wynn TA, Chang Y et al. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med 1997; 185: 1959-1968.
8. Gao W, Topham PS, King JA et al. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection. J Clin Invest 2000; 105: 35-44.
9. Eis V, Luckow B, Vielhauer V et al. Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction. J Am Soc Nephrol 2004; 15: 337-347.
10. Anders HJ, Belemezova E, Eis V et al. Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice. J Am Soc Nephrol 2004; 5: 1504-1513.
11. Anders HJ, Frink M, Linde Y et al. CC chemokine ligand 5/RANTES chemokine antagonists aggravate glomerulonephritis despite reduction of glomerular leukocyte infiltration. J Immunol 2003; 170: 5658-5666.
12. Shimizu S, Nakashima H, Karube K et al. Monocyte chemoattractant protein-1 activates a regional Th1 immunoresponse in nephritis of MRL/lpr mice. Clin Exp Rheumatol 2005; 23: 239-242.
13. Furuichi K, Wada T, Sakai N et al. Distinct expression of CCR1 and CCR5 in glomerular and interstitial lesions of human glomerular diseases. Am J Nephrol 2000; 20: 291-299.
14. Vielhauer V, Anders HJ, Mack M et al. Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2 and 5 positive leukocytes. J Am Soc Nephrol 2001; 12: 1173-1187.
15. Anders HJ, Vielhauer V, Frink M et al. A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. J Clin Invest 2002; 109: 251-259.
16. Vielhauer V, Berning E, Linde Y et al. A CCR1 antagonist reduces interstitial nephritis and fibrosis, but not proteinuria and glomerular pathology in murine adriamycin nephropathy. Kidney Int 2004; 66: 2264-2278.
17. Rodgers KD, Rao V, Meehan DT et al. Monocytes may promote myofibroblast accumulation and apoptosis in Alport renal fibrosis. Kidney Int 2003; 63: 1338-1355.
18. Chow F, Ozols E, Nikolic-Paterson DJ et al. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int 2004; 65: 116-128.
19. Horuk R, Shurey S, Ng HP et al. CCR1-specific non-peptide antagonist: efficacy in a rabbit allograft rejection model. Immunol Lett 2001; 76: 193-201.
20. Bedke J, Kiss E, Horuk R et al. Blockade of rat chemokine receptor CCR-1 by BX471 reduces acute rejection and is able to reduce chronic allograft nephropathy. Kidney Blood Press Res 2004; 5: 290.